Abstract

Tobacco is mostly commonly used drug which is the foremost preventable cause of death and disease in the world today. It is of major public health concern for countries in the southeast region.India faces a dual burden of tobacco use in the form of smoking and smokeless tobacco. With wide variation in smokeless tobacco consumption in India, the prevalence is higher in rural population. Tobacco use is a major risk factor for various infectious and Non-communicable Diseases. Participation of health care professionals in tobacco cessation is the need of the hour. Training the healthcare professionals for behavioural counselling and addiction management would serve the need to reduce the burden of tobacco related diseases. The association between tobacco usage and the various oral diseases are well recognized now. With the incorporation of Tobacco cessation counselling centre in all dental colleges across India, Dentists are nowadays trained for behavioural management of patients.

• 1.   Preeti S, Raut DK. Prevalence and Pattern of Tobacco Consumption in India. Int Res J Social Sci. 2012;1(4):36-43.
• 2.   WHO Framework Convention on Tobacco Control [Internet]. World Health Organization. 2021 [cited 5 December 2021]. Available from: https://www. who.int/fctc/text_download/en/.
• 3.   Ramakrishna GS, Sarma P, Thankappan KR, Tobacco Use among Medical Students in Orissa. Natl Med J India. 2005:18(1):285-99.
• 4.   MPOWER A Policy Package to Reverse the Tobacco Epidemic [Internet]. Apps.who.int. 2007 [cited 5 December 2021]. Available from: https://apps.who.int/iris/bitstream/hand le/10665/43888/9789241596633_eng.pdf.
• 5.   Global Tobacco Control [Internet]. Centers for Disease Control and Prevention. 2019 [cited 5 December 2021]. Available from: https://www. cdc.gov/tobacco/global/index.htm.
• 6.   Nethan ST, Sinha DN, Chandan K, Mehrotra R. Smokeless tobacco cessation interventions: A systematic review. Indian J Med Res. 2018;148(4):396–410.
• 7.   World Health Organization, Regional Office for SouthEast Asia. WHO Factsheet 2018, India. [Internet]. Apps.who.int. 2018 [cited 5 December 2021]. Available from:https://apps.who.int/iris/ bitstream/handle/10665/272672/wntd_2018_ india_fs.pdf?sequence=1&isAllowed=y. Published 2018. Accessed 20 December, 2020.
• 8.   Global Adult Tobacco Survey - 2 [Internet]. Ntcp.nhp.gov.in. 2021 [cited 5 December 2021]. Available from: https://ntcp.nhp.gov.in/assets/ document/surveys-reports-publications/GATS- 2-FactSheet.pdf.
• 9.   Mumbai and Ministry of Health and Family Welfare, Government of India, World Health Organization, Centers for Disease Control and Prevention, Tata Institute of Social Sciences. GATS 2: Global Adult Tobacco Survey - India 2016-17. [cited 5 December 2021]. Available from:https:// www.who.int/tobacco/surveillance/survey/ gats/GATS_India_2016-17_FactSheet.pdf.
• 10.   Jha P, Jacob B, Gajalakshmi V, Gupta PC, Dhingra N, Kumar R et al. A Nationally Representative Case–Control Study of Smoking and Death in India. New Engl J Med. 2008;358(10):1-9.
• 11.   Sinha DN, Palipudi KM, Gupta PC, Singhal S, Ramasundarahettige C, Jha P, Indrayan A, Asma S, Vendhan G. Smokeless tobacco use: a meta-analysis of risk and attributable mortality estimates for India. Indian J Cancer. 2014 Dec;51 Suppl 1:S73-7. 12.
• 12.   World Health Organization. WHO global report on mortality attributable to tobacco [Internet]. Apps.who.int. 2012 [cited 5 December 2021]. Available from: https://apps.who.int/iris/ handle/10665/44815 13. Rai B, Bramhankar M. Tobacco use among Indian states: Key findings from the latest demographic health survey 2019–2020. Tob Preven Cess. 2021;7(March):19-20.
• 14.   John RM, Rout SK, Kumar RB, Arora M. Economic burden of tobacco related diseases in India. New Delhi: Ministry of Health & Family Welfare, Government of India. [Internet]. 2014 [cited 5 December 2021]. Available from: https://mohfw. gov.in/node/3236.
• 15.   Solhi M, Fattahi E, Manzari ZS, Gupta Pc, Kargar M, Kasmaei P et al. The Reasons for Using Smokeless Tobacco: A Review. Iran J Public Health 2021;50(3):492-501.
• 16.   Mehrtash H, Duncan K, Parascandola M, David A, Gritz ER, Gupta PC, et al. Defining a global research and policy agenda for betel quid and areca nut. Lancet Oncol. 2017 Dec;18(12):e767-75.
• 17.   Lee CH, Chiang SL, Ko AM, Hua CH, Tsai MH, Warnakulasuriya S, et al. Betel-quid dependence domains and syndrome associated with betelquid ingredients among chewers: an Asian multicountry evidence. Addiction. 2014 Jul;109(7):1194- 204.
• 18.   Noncommunicable diseases country profiles 2018 [Internet]. Who.int. 2018 [cited 6 December 2021]. Available from: https://www.who.int/ publications-detail-redirect/9789241514620.
• 19.   Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med 2004;164(20):2206-16.
• 20.   Bauer CMT, Morissette MC, Stämpfli MR. The Influence of Cigarette Smoking on Viral Infections: Translating Bench Science to Impact COPD Pathogenesis and Acute Exacerbations of COPD Clinically. Chest 2013;143(1):196-206.
• 21.   Gotts JE, Jordt SE, McConnell R, Robert Tarran R. What are the respiratory effects of e-cigarettes? BMJ 2019;366(1):l5275.
• 22.   Kumar M, Poorni S, Ramachandran S. Tobacco Use among School Children in Chennai City, India. Indian J Cancer 2006:43(1):127-31.
• 23.   Garg A, Chaturvedi P, Gupta PC. A review of the systemic adverse effects of areca nut or betel nut. Indian J Med Paediatr Oncol 2014; 35:3–9.
• 24.   Stanfill SB, Connolly GN, Zhang L, Jia LT, Henningfield JE, Richter P, et al. Global Surveillance of Oral Tobacco Products: Total Nicotine, Unionised Nicotine and TobaccoSpecific N-Nitrosamines. Tobacco Control 2011 May;20(3):e2-10.
• 25.   World Health Organization. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 89: Smokeless Tobacco and Some Tobacco-Specific N-Nitrosaminespdf iconexternal icon.[PDF–3.18 MB] Lyon (France): World Health Organization, International Agency for Research on Cancer. [Internet]. Nyfzx.com. 2008 [cited 6 December 2021]. Available from: http://nyfzx. com/PDF/cancer/mono97.pdf.
• 26.   The Health Consequences of Smoking—50 Years of Progress [Internet]. National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. 2014 [cited 6 December 2021]. Available from: h t t p s : // w ww . nc b i . n l m. n i h . g o v/ bo o k s / NBK179276/?report=reader.
• 27.   Sinha DN, Abdulkader RS, Gupta PC. Smokeless tobacco-associated cancers: A systematic review and meta-analysis of Indian studies. Int J Cancer. 2016 Mar 15;138(6):1368-79.
• 28.   Mishra A, Chaturvedi P, Datta S, Sinukumar S, Joshi P, Garg A. Harmful effects of nicotine. Indian J Med Paediatr Oncol 2015;36:24-31.
• 29.   Guidelines for the Implementation of Article 14 of the Who Framework Convention on Tobacco Control (Demand Reduction Measures Concerning Tobacco Dependence And Cessation) [Internet]. Who.int. 2010 [cited 6 December 2021]. Available from: http://www.who.int/fctc/Guidelines.pdf.
• 30.   Carr A, Ebbert J. Interventions for tobacco cessation in the dental setting. Cochrane Database Syst Rev 2006; 2016(1):CD005084.
• 31.   Centers for Disease Control and Prevention. Global tobacco surveillance system data (GTSSData). Atlanta, GA: Centers for Disease Control and Prevention. [Internet]. Apps.who.int. 2018 [cited 5 December 2021]. Available from: https://www.cdc. gov/ tobacco/global/gtss/gtssdata/index.html.
• 32.   WHO. WHO report on the global tobacco epidemic 2017. Geneva: World Health Organization. [Internet]. Apps.who.int. 2017 [cited 5 December 2021]. Available from: http://www.who.int/ tobacco/ global_report/2017/en/.
• 33.   Ebbert JO, Elrashidi MY, Stead LF. Interventions for smokeless tobacco use cessation. Cochrane Database Syst Rev 2015; 2015(10):CD004306.
• 34.   Mehrotra R, Yadav A, Sinha DN, Parascandola M, John RM, Ayo-Yusuf O, et al. Smokeless tobacco control in 180 countries across the globe: call to action for full implementation of WHO FCTC measures. Lancet Oncol. 2019 Apr;20(4):e208-e17.
• 35.   FCTC Global Knowledge Hub on Smokeless Tobacco, India. Research, Surveillance and Exchange of Information on SLT [Internet]. 2017 [cited 6 December 2021]. Available from: http:// www.untobaccocontrol.org/ kh/smokelesstobacco/background-documents/#factsheets.
• 36.   Mehrotra R, Grover S, Chandra A. Role of World Health Organization Framework Convention on Tobacco Control Global Knowledge Hub on Smokeless Tobacco. Indian J Med Res 2018; 148: 7–13.
• 37.   WHO Framework Convention on Tobacco Control. Conference of the Parties to the WHO Framework Convention on Tobacco Control. Sixth session. Moscow, Russian Federation, 13–18 October 2014. Provisional agenda item 4.4.1. Control and prevention of smokeless tobacco products. Geneva: World Health Organization. [Internet]. Apps.who. int. 2014 [cited 5 December 2021]. Available from: http://apps.who.int/gb/fctc/PDF/cop6/FCTC_ COP6_9-en.pdf.
• 38.   Mehrotra R, Grover S, Chandra A. Role of World Health Organization Framework Convention on Tobacco Control Global Knowledge Hub on Smokeless Tobacco. Indian J Med Res 2018; 148:7– 13.
• 39.   Murukutla N. “Module 5: Tobacco Control Interventions: Part II.” Global Tobacco Control Program, The Johns Hopkins University. Apr. 2021, www.globaltobaccocontrol.org/sites/ default/files/2021-04/Transcript-Module_5-PartII.pdf. Accessed Mar. 2024.
• 40.   Noar SM, Hall MG, Francis DB, Ribisl KM, Pepper JK, Brewer NT. Pictorial cigarette pack warnings: a meta-analysis of experimental studies. Tob Control 2016;25:341–354.
• 41.   Mohanty VR, Rajesh GR, Aruna DS. Role of Dental Institutions in Tobacco Cessation in India: Current Status and Future Prospects. Asian Pacific J Cancer Prev. 2013;14(4):2673-80.
• 42.   Varghese C, Kaur J, Desai NG, Murthy P, Malhotra S, Subbakrishna DK, et al. Initiating tobacco cessation services in India: challenges and opportunities. WHO South-East Asia J Public Health 2012;1:159-68.
• 43.   Holliday R, Hong B, McColl E, Livingstone-Banks J, Preshaw PM. Interventions for tobacco cessation delivered by dental professionals. Cochrane Database Syst Rev 2021:2021(2):CD005084.
• 44.   Mishra GA, Pimple SA, Shastri SS. An overview of the tobacco problem in India. Indian J Med Paed Oncol 2012 Jul-Sep;33(3):139-45.

Data Sharing Statement

Funding